![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
Advertisement
All
>
Persons > Switzerland
Find below all kinds of persons from Switzerland (Schweiz / Suisse).Total search results: 1314 | Ordered by Person (ascending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 
  Person |
 Position |
Organisation (Group) |
Region |
|---|---|---|---|
| Abbey, Jeffrey (Jeff) (ImmunOs Therapeutics 202109– COO before Independent Consultant + Novadip Biosciences + Argos Tx) | Chief Operating Officer (COO) | ImmunOs Therapeutics AG | Zürich (region) |
| Abdulkin, Pavel (Microcaps 202103 Sales + Business Development) | Sales Manager / Marketing Manager | Microcaps AG | Zürich (region) |
| Abend, Sven (Lonza 201903– COO of Lonza Specialty Ingredients segment) | President/Director/Head Business Group/Unit/Division | Lonza (Group) | Northwestern Switzerland (region) |
| Abraham, Eytan (Lonza 201710 RnD Associate Director) | n. a. | Lonza (Group) | Northwestern Switzerland (region) |
| Acharya, Mukta (Tecan 202408– promoted to Head of Life Sciences Business joined 7/22 before Thermo Fisher + CVS Health) | President/Director/Head Business Group/Unit/Division | Tecan (Group) | Zürich (region) |
| Adams, Timothy M. (Tim) (ObsEva 201701– CFO located in US before Demandware + athenahealth + Cytyc) | Chief Financial Officer (CFO) | ObsEva (Group) | Région Lémanique (region) |
| Aebersold, Ruedi (ETH Zurich 2005c– Professor Systems Biology before Institute of Systems Biology Seattle) | Professor | ETH Zürich (ETHZ) | Zürich (region) |
| Aebischer, Patrick (Ecole Polytechnique Fédérale 200808) | n. a. | EPFL (Ecole Polytechnique Fédérale de Lausanne) | Région Lémanique (region) |
| Affentranger, Anton (Affentranger Associates 200803 CEO + Senior Partner + founder before Roche CFO) | Chief Executive Officer (CEO) | Affentranger Associates S.A. | Région Lémanique (region) |
| Ahrens, Nikolai (Turos Capital 2018– Founder + CEO + LifeScience Connect 2020 Founder) | n. a. | Turos Capital AG | Zürich (region) |
| Akhmedov, Murodzhon (BigOmics 202203 CEO + Co-Founder) | Chief Executive Officer (CEO) | BigOmics Analytics S.A. | Switzerland_other |
| Alanine, Alexander (Bactevo 201704– COO before Roche) | Chief Operating Officer (COO) | Astellas (Group) | East of England (region) |
| Alberti, Claudio (GenomSys 201909 CTO + Co-Founder) | Chief Technology/Technical Officer (CTO) | GenomSys S.A. | Région Lémanique (region) |
| Alexakis, Domenico P. (Swiss Biotech Association 201611 CEO) | Chief Executive Officer (CEO) | Swiss Biotech Association (SBA) | Zürich (region) |
| Alexander, David (Adecco 201709 President North America Financa, Office + Healthcare businesses) | President/Director/Head Business Group/Unit/Division | Adecco (Group) | Zürich (region) |
| Alldread, Richard (Lonza 201107 Head Technology Development + Strategic Projects at Lonza Development Services) | Technical Manager | Lonza (Group) | Northwestern Switzerland (region) |
| Allemond, Pierre (Protein Metrics 201510– VP European Sales before Biovia/Dassault Systèmes + Accelrys + Chemspeed) | Sales Manager / Marketing Manager | Insightful Science (Group) | Région Lémanique (region) |
| Allen, Keith (Syngenta Biotechnology Inc. 200604) | n. a. | Syngenta (Group) | Northwestern Switzerland (region) |
| Allocca, Antonietta (Tecan 201611) | Sales Manager / Marketing Manager | Tecan (Group) | Zürich (region) |
| Alramahy, Ehab (Biosynth 202309 SVP Head of Peptide Division) | President/Director/Head Business Group/Unit/Division | Biosynth (since 9/22) (Group) | Switzerland_other |
| Altendorf, Matthias (Endress+Hauser 202401– Supervisory Board Chair before CEO 2014–202312) | Supervisory Board Member | Endress+Hauser (Group) | Northwestern Switzerland (region) |
| Althoff, Gioia (Sophia Genetics 201904 SVP Genomics) | President/Director/Head Business Group/Unit/Division | Sophia Genetics (Group) | Région Lémanique (region) |
| Altmeyer, Mark (Arvelle Therapeutics 201902– CEO before Axovant Sciences + BMS + Otsuka America Pharmaceutical) | Chief Executive Officer (CEO) | Angelini (Group) | Central Switzerland (region) |
| Altorfer, Michael (Swiss Biotech Association 201811 CEO before Polyphor + Roche + Ciba-Geigy + Sandoz + UBS Warburg) | Chief Executive Officer (CEO) | Swiss Biotech Association (SBA) | Zürich (region) |
| Álvarez Sánchez, Herminia (Nagi Bioscience 202309 Marketing + Business Development) | Sales Manager / Marketing Manager | Nagi Bioscience S.A. | Région Lémanique (region) |
| Ambros, Reinhard (Versameb 201910c Board Chairman + Novartis Venture Fund) | Board member, non-executive | Versameb AG | Northwestern Switzerland (region) |
| Amiguet, Claude (Neode 2003– Director) | President/Director/Head Business Group/Unit/Division | Neode Science and Technology Park Neuchâtel | Espace Mittelland (region) |
| Amstutz, Patrick (Molecular Partners 201705– CEO before acting CEO before COO + Co-Founder) | Chief Executive Officer (CEO) | Molecular Partners AG (SIX: MOLN, Nasdaq: MOLN) | Zürich (region) |
| Anderson, William N. (Bill) (Bayer 202306– CEO before Roche + Genentech + Biogen Idec + Raychem) | Chief Executive Officer (CEO) | Bayer (Group) | Nordrhein-Westfalen (federal state) |
| Ando, Goran (Nouscom 202311 Independent Chair) | Board member, non-executive | Nouscom (Group) | Northwestern Switzerland (region) |
| Andrier, Gilles (Givaudan 201402 CEO) | Chief Executive Officer (CEO) | Givaudan (Group) | Switzerland_other |
| Angehrn Pavik, Barbara (Asceneuron 202310– CEO before Vifor + Stepstone Pharma + Exelixis + Onyx + Amgen) | Chief Executive Officer (CEO) | Asceneuron S.A. | Région Lémanique (region) |
| Antener, Mathias (Creoptix 202201 Head of Marketing) | Public Relations Manager / Investor Relations Manager | Spectris (Group) | Zürich (region) |
| Appel, Robert (MCH Group 201207 ILMAC Exhibition Manager) | n. a. | MCH Group AG | Northwestern Switzerland (region) |
| Appelmann, Karl (Gentium 201111– Country Manager DE+ AT + CH before ViroLogik 201105 Managing Director) | Regional manager | Jazz Pharmaceuticals (Group) | Central Switzerland (region) |
| Applebaum, Scott (VectivBio 202109– Chief Legal Officer + Corp Secretary before Trevena + Context Tx + Vitae + Medgenics | General Counsel / Chief Legal Officer (CLO) | Ironwood (Group) | Northwestern Switzerland (region) |
| Aradhye, Shreeram (Novartis 201801 Global Head of Medical Affairs + CMO) | Chief Medical Officer (CMO) | Novartis (Group) | Northwestern Switzerland (region) |
| Aregger, Melanie (Avelo 202209 CEO + Co-Founder) | Chief Executive Officer (CEO) | Avelo AG | Zürich (region) |
| Arigoni, Markus (Micro-Macinazione 201708 CEO) | Chief Executive Officer (CEO) | Lonza (Group) | Switzerland_other |
| Artusio, Lionel (Z Impact Ventures 202407 General Partner) | General Partner (venture partner) | Z Impact Ventures (d/b/a Zebra Impact Ventures) | Région Lémanique (region) |
| Asam, Alexander (HBM Partners 201304 Investment Advisor before Kaneas Capital 2006– founder before DVC) | Investment Manager | HBM (Group) | Central Switzerland (region) |
| Attinger, Per-Olof (Roche 199201– Head of Coporate Communication) | communication policy | Roche (Group) | Northwestern Switzerland (region) |
| Augello, Frank A. | n. a. | Qiagen (Group) | Zürich (region) |
| Augsburger, Marc (CURML-UTCF 201005 Operational Manager) | n. a. | University of Lausanne (UNIL) | Région Lémanique (region) |
| Augustin, Marc (PolyPeptide 2024Q1– CFO before Lonza + Smith & Nephew Orthopaedics + Alcoa Extrusion + Thyssen Krupp) | Chief Financial Officer (CFO) | PolyPeptide (Group) | Central Switzerland (region) |
| Ayyoubi, Silvia (Roche 200803–201603 Head of Global Human Resources + Member of Corp Executive Committe RETIRED 3/16) | Human Resources Manager | Roche (Group) | Northwestern Switzerland (region) |
| Azam, Usman (Oz) (Tmunity Therapeutics 201612– CEO before Novartis + Novaccel + Aspreva + JnJ) | Chief Executive Officer (CEO) | Gilead Sciences (Group) | Pennsylvania (federal state) |
| Azzaoui, Kamal (Saverna Therapeutics 2017– CEO + Co-Founder before Novartis) | Chief Executive Officer (CEO) | Saverna Therapeutics AG | Northwestern Switzerland (region) |
| Baag, Rima | n. a. | Danaher (Group) | Northwestern Switzerland (region) |
| Babiss, Lee E. (Gotham Therapeutics 201810 CEO before Roche+ PPD + Glaxo Wellcome) | Chief Executive Officer (CEO) | Gotham Therapeutics (Group) | New York (federal state) |
| Bach, Dani (+ND Capital 202105 Partner formerly Aravis + Index Ventures) | Managing Partner (investment firm) | +ND Capital (f.k.a. NanoDimension) | Switzerland_other |
| Baehny, Albert M. (Lonza 202005 Board Chairman + interim CEO) | Board member, non-executive | Lonza (Group) | Northwestern Switzerland (region) |
| Baena, Jesús (Novartis 202002 Director Business Development) | Business Development Manager / Strategy Manager | Novartis (Group) | Northwestern Switzerland (region) |
| Baerlocher, Urs (Novartis –200708) | Board member, executive | Novartis (Group) | Northwestern Switzerland (region) |
| Bagaric, Marko (Berlin Cures 201802 CEO) | n. a. | Berlin Cures (Group) | Central Switzerland (region) |
| Bagger, Karsten (Neurosoft Bioelectronics 202103 CBO) | Chief Business Officer (CBO) | Neurosoft Bioelectronics (CH) | Région Lémanique (region) |
| Bahi, Khaled (Stilla Technologies 201911– CFO before Symetis + Fresenius Medical Care) | Chief Financial Officer (CFO) | Stilla Technologies (Group) | Île-de-France (region) |
| Bairoch, Amos (Swiss Institute of Bioinformatics 2009 Professor) | Professor | Swiss Institute of Bioinformatics (SIB) | Région Lémanique (region) |
| Balet, Eva-Maria (Evi) (Regenosca 202407 CEO + Co-Founder) | Chief Executive Officer (CEO) | Regenosca SA | Région Lémanique (region) |
| Ball, Mike (Novartis 201602 CEO of Alcon) | Chief Executive Officer (CEO) | Novartis (Group) | Central Switzerland (region) |
| Ballerini, Maurizio (Proteomedix 202006– VP Market Development EMEA before MDxHealth + GenProbe + Stryker + Randox) | Sales Manager / Marketing Manager | Proteomedix AG | Zürich (region) |
| Ballmer, Allison (Agilent 202101– SVP Strategy + Corporate Development joined 5/18 before Roche + Biocartis) | Business Development Manager / Strategy Manager | Agilent (Group) | California (federal state) |
| Ballmer, Patrick (Sotax 201611 Vice President) | President/Director/Head Business Group/Unit/Division | Sotax (Group) | Northwestern Switzerland (region) |
| Ballotta, Virginia (BaseLaunch 202210 Manager New Ventures) | Business Development Manager / Strategy Manager | Basel (govt city) | Northwestern Switzerland (region) |
| Baloh, Robert (Novartis 202411 Global Head of Neuroscience Research) | President/Director/Head Business Group/Unit/Division | Novartis (Group) | Northwestern Switzerland (region) |
| Baltisberger, Matthias M. (Roche 200609 Head of Roche Basel) | n. a. | Roche (Group) | Northwestern Switzerland (region) |
| Barberis, Alcide (Telormedix 201109 Head Research + Collaborations before Oncalis CSO/COO + ESBATech CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Telormedix S.A. | Ticino (region) |
| Barbut, Jack (Novimmune 201012–201512 CEO until 12/15) | Chief Executive Officer (CEO) | Novimmune S.A. | Région Lémanique (region) |
| Barra, Cédric (Occident Group 201808 Investment Manager) | Investment Manager | Occident (Group) | Central Switzerland (region) |
| Barrett, Elizabeth (Liz) (UroGen 201901– CEO before CEO Novartis Oncolgoy + Pfizer + Cephalon + JnJ) | Chief Executive Officer (CEO) | UroGen Pharma Ltd. (Nasdaq: URGN) | Israel_o |
| Barril, Xavier (Gain Therapeutics 201802 CSO before Minoryx Therapeutics + Vernalis) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Gain Therapeutics (Group) | Ticino (region) |
| Barton, Claire (T3 Pharmaceuticals 201909– CMO before Roche + Lilly + GW) | Chief Medical Officer (CMO) | Boehringer Ingelheim (Group) | Northwestern Switzerland (region) |
| Bates, Gordon (Lonza 201610 SVP Business Unit Head Chemical + Microbial Manufacturing) | President/Director/Head Business Group/Unit/Division | Lonza (Group) | Northwestern Switzerland (region) |
| Batur, Gökhan (Polyphor 202001– promoted to CEO joined 201906 as CCO before Merck (US)) | Chief Executive Officer (CEO) | Spexis (Group) | Northwestern Switzerland (region) |
| Batzl-Hartmann, Christine (Pharmacelsus 201110 Managing Director (CEO) + Founder before Novartis) | Managing Director | Pharmacelsus GmbH | Saarland (federal state) |
| Bauer, Ariel (SGS 202401 Group VP Investor Relations, Communications + Sustainability) | Public Relations Manager / Investor Relations Manager | SGS (Group) | Région Lémanique (region) |
| Bauer, Erwin P. (BB Medtech 2003–200704 Verwaltungsrat) | n. a. | Bellevue (Group) | Zürich (region) |
| Bauer, Michael (Quantro Therapeutics 202305– CEO before Cellestia Biotech CEO) | Chief Executive Officer (CEO) | Quantro Therapeutics GmbH | Wien (state) |
| Baumann, Oliver R. (Xlife Sciences 202103 CEO) | Chief Executive Officer (CEO) | Xlife Sciences AG (SIX: XLS) | Zürich (region) |
| Baumann, Urs (Bellevue Group 201409 CEO) | Chief Executive Officer (CEO) | Bellevue (Group) | Zürich (region) |
| Baumert, Thomas F. (Univ Stasbourg 201904 Professor + Scientific Founder of Alentis Therapeutics) | Professor | University of Strasbourg | Grand Est (Great East) (region) |
| Bausch, Alexander (Kinarus 202208 CEO and Strekin 201705 CEO + Co-Founder) | Chief Executive Officer (CEO) | Strekin AG | Northwestern Switzerland (region) |
| Beck, Jürgen (Memo Therapeutics 202306 CMO before prosion + Paion + Intermune + Epigenomics + Synthélabo) | Chief Medical Officer (CMO) | Memo Therapeutics AG (MTx) | Zürich (region) |
| Becker, Marc (CRISPR Therapeutics 201603– CFO before rEVO Biologics + Genzyme) | Chief Financial Officer (CFO) | CRISPR Therapeutics (Group) | Northwestern Switzerland (region) |
| Beckman, Evan (Novartis 201803 Head of Translational Medicine at Novartis Institutes for BioMedical Research) | Research & Development Manager | Novartis (Group) | Northwestern Switzerland (region) |
| Béduer, Amélie (Volumina Medical 202403 CEO + Co-Founder) | Chief Executive Officer (CEO) | Volumina Medical S.A. | Région Lémanique (region) |
| Beeler, Kristina (Biognosys 202105– CBO before Head of Business Development joined 2017 before Nextech Invest) | Chief Business Officer (CBO) | Bruker (Group) | Zürich (region) |
| Behar, Greg (Recipharm 202401– CEO before CEO of Nestlé Health Science before Novartis + Boehringer Ingelheim) | Chief Executive Officer (CEO) | Recipharm (Group) | Sweden_o |
| Beher, Dirk (FundaMental Pharma 202404– CEO before Asceneuron + MSD UK + Amgen + Merck Serono) | Chief Executive Officer (CEO) | FundaMental Pharma GmbH (FMP) | Baden-Württemberg (federal state) |
| Behr, Pascal (Cytosurge 201806 CEO) | Chief Executive Officer (CEO) | Cytosurge AG | Zürich (region) |
| Belawat, Priyanka (HBM 201806 Investment Advisor at HBM Partners) | Consultant (economic/technology) | HBM (Group) | Central Switzerland (region) |
| Bellotto, Manolo (Gain Therapeutics 202009 President + General Manager) | General Manager (management) | Gain Therapeutics (Group) | Ticino (region) |
| Ben Faleh, Ahmed (IsoSpec Analytics 202404 CEO + Co-Founder) | Chief Executive Officer (CEO) | IsoSpec Analytics SA | Région Lémanique (region) |
| Ben-Zeev, Iris (Kenes 201308 Event Manager) | Event Manager / Conference Manager | Kenes (Group) | Région Lémanique (region) |
| Bender, Norbert (Evolva 201105– CMO before ViroLogik + Trigen + Carion + Hoechst + Knoll) | Chief Medical Officer (CMO) | Lallemand (Group) | Northwestern Switzerland (region) |
| Benedict, Nicholas (Vaderis Therapeutics 202208 CEO + Co-Foudner formerly Allecra Therapeutics) | Chief Executive Officer (CEO) | Vaderis Therapeutics AG | Northwestern Switzerland (region) |
| Benz, Rolf (Sotax Holding 200810 CEO) | Chief Executive Officer (CEO) | Sotax (Group) | Northwestern Switzerland (region) |
| Berg, Niclas (Zeria 202307 Lead Corporate Communications at Tillotts Pharma) | Public Relations Manager / Investor Relations Manager | Zeria (Group) | Switzerland_other |
| Bernard, Raphaël (GenomSys 201909 Marketing + Communications Manager) | Sales Manager / Marketing Manager | GenomSys S.A. | Région Lémanique (region) |
| Bernasconi, Stefano (ETH Zürich 201512 Professor) | Professor | ETH Zürich (ETHZ) | Zürich (region) |
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
